Healthcare for Antimicrobial Resistance -myassignmenthelp.com

Question: Do you think by developing new antibiotics we are actually solving the problem of Antibiotic or antimicrobial resistance ? Answer: At the present times, the medical research arena seems to be running out of antibiotics. While there were only two new classes of antibiotics in the market in the 1960s, the middle of the 20th century has witnessed around 20 new classes of antibiotics. Antibiotic resistance is a key concern of modern health system as the evolution of microbial pathogens is more advanced than the evolution of antibiotic properties. Development of new antibiotics rests on the desire to solve the problem of antibiotic resistance (Ventola 2015). In my opinion, by developing new antibiotics, we are not actually solving the problem of antimicrobial resistance. As opined by Sommer et al. (2017) the issue of antibiotic resistance is primarily due to the abuse of antibiotics. Individuals from across the communities have the inclination towards taking antibiotics for medical complications that could have been addressed through other forms of medication or other treatment processes. Antibacterial compounds have specific targets, and in a normal human body, such compounds have other adverse effects. In addition, completion of the full course of the prescribed antibiotics is a serious concern, leading to resistance. Antibiotics are also taken prophylactically, as a form of preventive measure for infections, leading to resistance. If antibiotic resistance is to be curbed at an immediate basis, there is a need to address the above mention challenges. Developing new antibiotics and successive failure to address antibiotic resistance will be a continual process if the cycle is not stopped at the level of misuse of antibiotic. It is only when the publ ic is aware of the appropriate use of antibiotics that development of new antibiotics would be successful in solving the problem of resistance. References Sommer, M.O., Munck, C., Toft-Kehler, R.V. and Andersson, D.I., 2017. Prediction of antibiotic resistance: time for a new preclinical paradigm?.Nature Reviews Microbiology, pp.nrmicro-2017. Ventola, C. L. 2015. The Antibiotic Resistance Crisis: Part 1: Causes and Threats.Pharmacy and Therapeutics,40(4), pp. 277283.